Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Diagnostic Solutions Company Expands Quality Control Offering

By LabMedica International staff writers
Posted on 29 Jun 2010
A new range of lyophilised quality controls ensures longer shelf life and stability, resulting in greater continuity of lot supply. More...
Other advantages of the new quality controls include more convenient storage at 2 °C - 8 °C and easier transportation.

The quality control sera are manufactured by Randox Laboratories (Crumlin, UK). Quality control guarantees good performance and ensures that results are of high quality and reliability. The company's Acusera range of quality controls currently covers over 290 parameters and is set to expand with the introduction of several new quality controls.

The new quality controls include coagulation, maternal screening, clinical chemistry, immunoassays, tumor markers, HbA1c, and thalassemia. Randox quality controls are true third party controls in that they are not designed or optimized for use with a specific manufacturer's instrument, calibrator, or reagent.

In addition to the extensive range of quality control materials Randox provides 24/7 an internet driven peer-group reporting system and RIQAS, an external quality assurance scheme providing customers with 15 external quality assessment (EQA) programs.

Randox develops, manufactures, and markets clinical diagnostic products including the Biochip Array Technology, clinical chemistry analyzers and reagents, quality controls, and EQA, as well as a complete life science range.

Related Links:
Randox Laboratories


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.